01.09.2003 | ORIGINAL ARTICLE
Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study
Erschienen in: Clinical and Experimental Nephrology | Ausgabe 3/2003
Einloggen, um Zugang zu erhalten